FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017109715> ?p ?o ?g. }

• W2017109715 endingPage "25" @default.
• W2017109715 startingPage "22" @default.
• W2017109715 abstract "The optimal treatment of advanced sporadic Burkitt lymphoma in adults is still a matter of debate. The salutary results of pediatric therapies did open the road for improving the adult outcome. Between May 1988 and March 2009, 71 consecutive patients—46 adults, 25 children—affected by Burkitt lymphoma/leukemia were treated with the same intensive pediatric protocol alternating vincristine, adriamycine and fractionated ciclophosphamide (phase A) with high dose methotrexate and high dose cytarabine (phase B) in four Italian institutions. Eighty-nine per cent of patients were in Stage III–IV or had L3 leukemia. Complete remissions were 67/71 (94.4%), 24/25 (96%) in children, and 43/46 (93.5%) in adults. Toxic deaths were 3/71 (4.2%), all in adults. There were nine relapses (one in children, eight in adults), all but one observed early. After a median observation of 94 months (range 23–275), the Event–Free Survival rate is 92% in children and 71.7% in adults (P = 0.067). The 23 more recent adults received also rituximab, without differences in outcome as compared to patients who did not. Our experience confirms that such an intensive pediatric-derived chemotherapy is feasible and improves the long-term outcome of adults with advanced Burkitt lymphoma. Am. J. Hematol., 2012. © 2011 Wiley Periodicals, Inc." @default.
• W2017109715 created "2016-06-24" @default.
• W2017109715 creator A5008693201 @default.
• W2017109715 creator A5024463077 @default.
• W2017109715 creator A5027542527 @default.
• W2017109715 creator A5036223053 @default.
• W2017109715 creator A5056541118 @default.
• W2017109715 creator A5059019994 @default.
• W2017109715 creator A5066461145 @default.
• W2017109715 creator A5069047062 @default.
• W2017109715 creator A5070044155 @default.
• W2017109715 creator A5073971614 @default.
• W2017109715 creator A5078958639 @default.
• W2017109715 creator A5081086326 @default.
• W2017109715 creator A5083942494 @default.
• W2017109715 creator A5086902762 @default.
• W2017109715 date "2011-11-16" @default.
• W2017109715 modified "2023-10-11" @default.
• W2017109715 title "Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemia" @default.
• W2017109715 cites W1533627074 @default.
• W2017109715 cites W1783838151 @default.
• W2017109715 cites W1832431868 @default.
• W2017109715 cites W1889566095 @default.
• W2017109715 cites W1912693401 @default.
• W2017109715 cites W1975280591 @default.
• W2017109715 cites W2001985588 @default.
• W2017109715 cites W2080777577 @default.
• W2017109715 cites W2093913386 @default.
• W2017109715 cites W2109118882 @default.
• W2017109715 cites W2116405848 @default.
• W2017109715 cites W2136320467 @default.
• W2017109715 cites W2144002645 @default.
• W2017109715 cites W2152645133 @default.
• W2017109715 cites W4251062918 @default.
• W2017109715 cites W60055175 @default.
• W2017109715 doi "https://doi.org/10.1002/ajh.22189" @default.
• W2017109715 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22086870" @default.
• W2017109715 hasPublicationYear "2011" @default.
• W2017109715 type Work @default.
• W2017109715 sameAs 2017109715 @default.
• W2017109715 citedByCount "28" @default.
• W2017109715 countsByYear W20171097152013 @default.
• W2017109715 countsByYear W20171097152014 @default.
• W2017109715 countsByYear W20171097152015 @default.
• W2017109715 countsByYear W20171097152016 @default.
• W2017109715 countsByYear W20171097152017 @default.
• W2017109715 countsByYear W20171097152018 @default.
• W2017109715 countsByYear W20171097152019 @default.
• W2017109715 countsByYear W20171097152020 @default.
• W2017109715 countsByYear W20171097152021 @default.
• W2017109715 countsByYear W20171097152022 @default.
• W2017109715 countsByYear W20171097152023 @default.
• W2017109715 crossrefType "journal-article" @default.
• W2017109715 hasAuthorship W2017109715A5008693201 @default.
• W2017109715 hasAuthorship W2017109715A5024463077 @default.
• W2017109715 hasAuthorship W2017109715A5027542527 @default.
• W2017109715 hasAuthorship W2017109715A5036223053 @default.
• W2017109715 hasAuthorship W2017109715A5056541118 @default.
• W2017109715 hasAuthorship W2017109715A5059019994 @default.
• W2017109715 hasAuthorship W2017109715A5066461145 @default.
• W2017109715 hasAuthorship W2017109715A5069047062 @default.
• W2017109715 hasAuthorship W2017109715A5070044155 @default.
• W2017109715 hasAuthorship W2017109715A5073971614 @default.
• W2017109715 hasAuthorship W2017109715A5078958639 @default.
• W2017109715 hasAuthorship W2017109715A5081086326 @default.
• W2017109715 hasAuthorship W2017109715A5083942494 @default.
• W2017109715 hasAuthorship W2017109715A5086902762 @default.
• W2017109715 hasBestOaLocation W20171097151 @default.
• W2017109715 hasConcept C126322002 @default.
• W2017109715 hasConcept C187212893 @default.
• W2017109715 hasConcept C2776694085 @default.
• W2017109715 hasConcept C2776755627 @default.
• W2017109715 hasConcept C2778041864 @default.
• W2017109715 hasConcept C2778336483 @default.
• W2017109715 hasConcept C2778461978 @default.
• W2017109715 hasConcept C2778913318 @default.
• W2017109715 hasConcept C2779338263 @default.
• W2017109715 hasConcept C2779429289 @default.
• W2017109715 hasConcept C2780653079 @default.
• W2017109715 hasConcept C2781059491 @default.
• W2017109715 hasConcept C2781107101 @default.
• W2017109715 hasConcept C2781413609 @default.
• W2017109715 hasConcept C2909962599 @default.
• W2017109715 hasConcept C71924100 @default.
• W2017109715 hasConceptScore W2017109715C126322002 @default.
• W2017109715 hasConceptScore W2017109715C187212893 @default.
• W2017109715 hasConceptScore W2017109715C2776694085 @default.
• W2017109715 hasConceptScore W2017109715C2776755627 @default.
• W2017109715 hasConceptScore W2017109715C2778041864 @default.
• W2017109715 hasConceptScore W2017109715C2778336483 @default.
• W2017109715 hasConceptScore W2017109715C2778461978 @default.
• W2017109715 hasConceptScore W2017109715C2778913318 @default.
• W2017109715 hasConceptScore W2017109715C2779338263 @default.
• W2017109715 hasConceptScore W2017109715C2779429289 @default.
• W2017109715 hasConceptScore W2017109715C2780653079 @default.
• W2017109715 hasConceptScore W2017109715C2781059491 @default.
• W2017109715 hasConceptScore W2017109715C2781107101 @default.
• W2017109715 hasConceptScore W2017109715C2781413609 @default.

• next